BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12781066)

  • 1. Limitations to the use of the CA-125 antigen level in ovarian cancer.
    Markman M
    Curr Oncol Rep; 2003 Jul; 5(4):263-4. PubMed ID: 12781066
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor markers in the management of patients with ovarian cancer.
    Tuxen MK; Sölétormos G; Dombernowsky P
    Cancer Treat Rev; 1995 May; 21(3):215-45. PubMed ID: 7656266
    [No Abstract]   [Full Text] [Related]  

  • 3. New technologies for the identification of markers for early detection of ovarian cancer.
    Bandera CA; Ye B; Mok SC
    Curr Opin Obstet Gynecol; 2003 Feb; 15(1):51-5. PubMed ID: 12544502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of ovarian cancer: promise and reality.
    Bast RC; Urban N; Shridhar V; Smith D; Zhang Z; Skates S; Lu K; Liu J; Fishman D; Mills G
    Cancer Treat Res; 2002; 107():61-97. PubMed ID: 11775462
    [No Abstract]   [Full Text] [Related]  

  • 5. CA 125 as a screening test for ovarian cancer.
    Hakama M; Stenman UH; Knekt P; Järvisalo J; Hakulinen T; Maatela J; Aromaa A
    J Med Screen; 1996; 3(1):40-2. PubMed ID: 8861050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin of ovarian cancer may have implications for screening.
    Tuma RS
    J Natl Cancer Inst; 2010 Jan; 102(1):11-3. PubMed ID: 20023201
    [No Abstract]   [Full Text] [Related]  

  • 7. Early detection of ovarian cancer.
    Teneriello MG; Park RC
    CA Cancer J Clin; 1995; 45(2):71-87. PubMed ID: 7889392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential and problems of screening for ovarian cancer.
    Yokoyama Y; Higuchi T; Mizunuma H
    Eur J Gynaecol Oncol; 2005; 26(3):241-3. PubMed ID: 15991520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Ovarian Cancer with CA 125 and Ultrasound Algorithm Does Not Reduce Mortality.
    Ebell MH
    Am Fam Physician; 2021 Oct; 104(4):422-423. PubMed ID: 34652113
    [No Abstract]   [Full Text] [Related]  

  • 10. [Challenge of evidence-based medicine: sense and non-sense of diagnostic tests in gynecology].
    Sehouli J; Stengel D; Hindenburg J; Camara O; Porzsolt F; Lichtenegger W;
    Zentralbl Gynakol; 2001 Mar; 123(3):127-31. PubMed ID: 11340951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the early detection of ovarian cancer: How to hear the whispers early.
    Cesario S
    Nurs Womens Health; 2010 Jun; 14(3):222-34. PubMed ID: 20579298
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis of ovarian cancer.
    Sundar S; Neal RD; Kehoe S
    BMJ; 2015 Sep; 351():h4443. PubMed ID: 26328593
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for ovarian cancer in the general population.
    Gentry-Maharaj A; Menon U
    Best Pract Res Clin Obstet Gynaecol; 2012 Apr; 26(2):243-56. PubMed ID: 22182415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice. Screening for ovarian cancer.
    Clarke-Pearson DL
    N Engl J Med; 2009 Jul; 361(2):170-7. PubMed ID: 19587342
    [No Abstract]   [Full Text] [Related]  

  • 15. Markers supplementing CA 125 in ovarian cancer.
    Stenman UH; Alfthan H; Vartiainen J; Lehtovirta P
    Ann Med; 1995 Feb; 27(1):115-20. PubMed ID: 7741989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer.
    Pisal N; Sindos M; Singer A
    J Natl Cancer Inst; 2003 Feb; 95(4):331; author reply 331-2. PubMed ID: 12591991
    [No Abstract]   [Full Text] [Related]  

  • 17. Is CA 125 actually a tumor marker for ovarian cancer?
    Collazos J
    Acta Oncol; 1995; 34(2):268. PubMed ID: 7718270
    [No Abstract]   [Full Text] [Related]  

  • 18. Status of tumor markers in ovarian cancer screening.
    Bast RC
    J Clin Oncol; 2003 May; 21(10 Suppl):200s-205s. PubMed ID: 12743135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the early detection of ovarian carcinoma.
    Garner EI
    J Reprod Med; 2005 Jun; 50(6):447-53. PubMed ID: 16050569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer screening: Current status and future directions.
    Nash Z; Menon U
    Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():32-45. PubMed ID: 32273169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.